Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

NCT07512076 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT07512076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07512076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
December 31, 2027
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly patients, pharmacokinetic study, prostate cancer patients